|
Chronic drinking more harmful for liver than acute or binge drinking (New Kerala)
Washington, Feb 4 : A new study on rodents has revealed that chronic drinking causes more injury - as measured by gene-expression changes - to the liver than acute or binge drinking.
(Feb 4, 2009)
Predicting Resistance To Breast Cancer Chemotherapy Treatment (Medical News Today)
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
(Feb 4, 2009)
Strengthening The Reporting Of Genetic Association Studies (Medical News Today)
Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health.
(Feb 4, 2009)
Research and Markets: New Strategies for Combating Bacterial Infection in this Essential Handbook (Centre Daily Times)
Research and Markets ( http://www.researchandmarkets. ) has announced the addition of John Wiley and Sons Ltd's new report " New Strategies Combating Bacterial Infection " to their offering.
(Feb 4, 2009)
BD to Issue Dividend (GenomeWeb News)
NEW YORK (GenomeWeb News) – Becton Dickinson said yesterday that its board of directors has declared a quarterly dividend of $.33 per common share. The dividend is payable on March 31 to shareholders of record on March 10.
(Feb 4, 2009)
Nasdaq Bumps DeCode from Global Market (GenomeWeb News)
NEW YORK (GenomeWeb News) — DeCode Genetics' stock has been moved from the Nasdaq Global Market to the Nasdaq Global Market after failing to maintain a minimum market value for listed shares, the company said today.
(Feb 4, 2009)
Roche Posts Double-Digit Increase in Full-Year Applied Science Revenues, Dip in MDx (GenomeWeb News)
NEW YORK (GenomeWeb News) – Roche today reported a 3 percent increase in full-year revenues for its diagnostics division, to 9.7 billion Swiss francs ($8.4 billion) from 9.4 billion Swiss francs ($8.1 billion) in 2007.
(Feb 4, 2009)
More Liver Injury Caused By Chronic Drinking Than Acute Or Binge Drinking (Medical News Today)
Alcohol consumption is known to cause liver damage. Yet the specifics of alcohol-induced liver injury can differ depending on the pattern of drinking. New rodent findings show that chronic drinking causes more injury - as measured by gene-expression changes - to the liver than acute or binge drinking.
(Feb 4, 2009)
Testing, Testing, 1, 2, 3 (GenomeWeb News)
At Bioinformatics Zen, Michael Barton wonders why he should write good software -- after all, he's not developing it for commercial use. He says, though, that the commercial principles of unit testing, automated building, and source control should be applied to scientific software development.
(Feb 4, 2009)
1 Step Closer To Personalized Medicine: Stroma Genomic Signature Predicts Resistance To Anthracyclin-Based ... (Medical News Today)
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
(Feb 4, 2009)
EMBL GeneCore purchases Genomatix's next generation sequencing data analysis solution (EurekAlert!)
( Genomatix Software GmbH ) The GeneCore of the European Molecular Biology Laboratory installed a Genomatix Mining Station and a Genomatix Genome Analyzer in Heidelberg, Germany. These systems deliver a complete and integrated analysis solution for Next Generation Sequencing data that can keep pace with the abundance of high quality data being produced at the EMBL's Genomics Core.
(Feb 4, 2009)
Scientists study Q fever pathogen (UPI)
BETHESDA, Md., Feb. 4 (UPI) -- U.S. scientists say they have uncovered genetic clues about why some strains of the pathogen that causes Q fever are more virulent than others.
(Feb 4, 2009)
Research and Markets: Animal Biotechnology - Technologies, Markets and Companies Gives Market Projections Right Up To ... (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering.
(Feb 4, 2009)
Scientists study Q fever pathogen (Moldova.org)
U.S. scientists say they have uncovered genetic clues about why some strains of the pathogen that causes Q fever are more virulent than others.Researchers from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center and the Virginia Bioinformatics Institute at Virginia Tech compared the sequences of four strains of Coxiella burnetii -- an intracellular bacterium that ...
(Feb 4, 2009)
Ovarian Cancer Prognostic Signature Reveals Key Pathways (GenomeWeb News)
NEW YORK (GenomeWeb News) – A new prognostic gene signature for ovarian cancer, described in PloS Medicine yesterday, is revealing ovarian cancer-related pathways and transcription factors that could help researchers close in on new treatments.
(Feb 4, 2009)
EMBL Purchases Genomatix's Software (GenomeWeb News)
NEW YORK (GenomeWeb News) — The European Molecular Biology Laboratory has installed genomics data mining and analysis tools from Genomatix Software in its Genomics Core Facility, the company said today.
(Feb 4, 2009)
23andMe, MondoBiotech Collaborate to Study Genetic Risk for Rare Diseases (GenomeWeb News)
Consumer genomics firm 23andMe and Switzerland-based MondoBiotech are collaborating on a global research project to uncover the genetic underpinnings of rare diseases, the partners announced last week.
(Feb 4, 2009)
New test predicts how breast cancer patients respond to chemotherapy (News-Medical-Net)
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
(Feb 4, 2009)
Navigenics Launches Cheaper Annual Genomic Service; Will Doctors Bite? (GenomeWeb News)
Navigenics last week launched a cheaper, stripped-down personal-genomics service meant to be integrated into individuals’ annual checkup in hopes that physicians will incorporate the resulting genetic-risk information in everyday health decision-making.
(Feb 4, 2009)
Mosquito genes linked to insecticide resistance may be new target in fight against malaria (EurekAlert!)
( Cold Spring Harbor Laboratory ) Malaria remains one of the most serious diseases worldwide, claiming more than one million lives per year, the majority of whom are children under five years of age. Efforts to eliminate this mosquito-borne illness rely heavily on prevention measures, but there are concerns about resistance to insecticides. In a study published online today in Genome Research, ...
(Feb 4, 2009)
Markers for diagnosis of cancer and its use (FreshPatents.com)
Disclosed herein are diagnostic markers CTHRC1, CANP and KIAA0101, which are overexpressed specifically in breast or colorectal cancer. A method for diagnosing the cancer by-detecting the markers, and a method for preventing or
(Feb 4, 2009)
Diagnosis and treatment of alzheimer's and other neurodementing diseases (FreshPatents.com)
Isolated, monoclonal, human, anti-β-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an Aβ polypeptide comprising Aβ(21-37)
(Feb 4, 2009)
UPI NewsTrack Health and Science News (UPI)
NASA scrubs weather satellite launch … Researchers find new schizophrenia gene … Japanese scientists find archaean genes … Scientists study Q fever pathogen ... Health/Science news from UPI.
(Feb 4, 2009)
What's killing the coral reefs? (EurekAlert!)
( DOE/Lawrence Berkeley National Laboratory ) A DNA microarray developed at Berkeley Lab may help scientists learn how to preserve coral, one of the ocean's most important denizens. The technology tracks changes in microbial populations that indicate coral disease.
(Feb 4, 2009)
Chronic drinking causes more liver injury than acute or binge drinking (News-Medical-Net)
Alcohol consumption is known to cause liver damage. Yet the specifics of alcohol-induced liver injury can differ depending on the pattern of drinking.
(Feb 4, 2009)
Prebys donation goes to Burnham (La Jolla Light)
Malin Burnham and John Reed flank Conrad Prebys at the dedication of the Conrad Prebys Center for Chemical Genomics. Photo by: Courtesy The event was billed as "What One Man Can Do." And what the man being honored has done is a lot. A host of speakers on Jan. 29 saluted philanthropist Conrad Prebys, whose $10 million donation to Burnham Institute for Medical Research will ...
(Feb 4, 2009)
Lenetix Launches Screening Study of New Down Syndrome Test (PR Newswire via Yahoo! Finance)
Lenetix, Inc. today announced the launch of an Institutional Review Board -approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome.
(Feb 5, 2009)
CLC Bio Launches Largest Software Update to Date and Now Includes Gene Expression Analyses (Business Wire via Yahoo! Finance)
AARHUS, Denmark----CLC bio just launched major updates to all their workbenches, resulting in the largest software update in the company's history. Other than a wide range of new features and improvements within sequence analysis, CLC bio's two top software products CLC Main Workbench and CLC Genomics Workbench now supports a full workflow in analysis of both digital- and analogue gene ...
(Feb 5, 2009)
CLC Bio Launches Largest Software Update to Date and Now Includes Gene Expression Analyses (Centre Daily Times)
CLC bio just launched major updates to all their workbenches, resulting in the largest software update in the company's history. Other than a wide range of new features and improvements within sequence analysis, CLC bio’s two top software products CLC Main Workbench and CLC Genomics Workbench now supports a full workflow in analysis of both digital- and analogue gene expression, such as ...
(Feb 5, 2009)
Illumina Presents Development Roadmap for Scaling its Genome Analyzer (Business Wire via Yahoo! Finance)
SAN DIEGO----Illumina, Inc. unveiled a development roadmap for its Genome Analyzer system that charts a path to generate greater than 95 Gigabases of high quality data per run in 2009.
(Feb 5, 2009)
IBC's 22nd International Antibody Development & Production Conference To Anchor Biopharmaceutical Development & ... (Medical News Today)
IBC is pleased to hold its 22nd International Antibody Development & Production Conference in Carlsbad, California on March 4-6, 2009.
(Feb 5, 2009)
Illumina Presents Development Roadmap for Scaling its Genome Analyzer (Centre Daily Times)
Illumina, Inc. (NASDAQ:ILMN) unveiled a development roadmap for its Genome Analyzer system that charts a path to generate greater than 95 Gigabases of high quality data per run in 2009. This roadmap, which was presented at a user-group meeting at this week’s Advances in Genome Biology and Technology (AGBT) conference, outlined advances in chemistry, algorithms, and hardware which will ...
(Feb 5, 2009)
Webinar : 'The Brave New World Of Non-Coding RNA's' (Medical News Today)
Distinguished Guest Speaker of the febit Science Lounge Webinar: Prof. Alexander Huettenhofer Division of Genomics & RNomics at the Medical University - Biocenter in Innsbruck (Austria) Tuesday, February 10, 2009 11:00 a.m. EST (5:00 p.m. CET) Webinar Login: http://www.febit.
(Feb 5, 2009)
Applied Biosystems Collaborates With Leading Medical Institution to Study Mechanisms of Cancer Development Using SOLiD ... (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----A team of researchers from the Mayo Clinic today announced preliminary data that demonstrates the advantages of sequencing-based approaches for associating structural variants with RNA expression profiles to identify potential biomarkers in head and neck cancer.
(Feb 5, 2009)
Applied Biosystems Collaborates With Leading Medical Institution to Study Mechanisms of Cancer Development Using SOLiD ... (Centre Daily Times)
A team of researchers from the Mayo Clinic today announced preliminary data that demonstrates the advantages of sequencing-based approaches for associating structural variants with RNA expression profiles to identify potential biomarkers in head and neck cancer. The data is the result of an ongoing scientific collaboration formed in 2008 between the Mayo Clinic and Applied Biosystems, a ...
(Feb 5, 2009)
EMBL GeneCore Purchases Genomatix's Next Generation Sequencing Data Analysis Solution (Medical News Today)
Genomatix Software, a leading provider of complete solutions for the analysis of Next Generation Sequencing (NGS) data, has announced that the European Molecular Biology Laboratory (EMBL) installed a Genomatix Mining Station and a Genomatix Genome Analyzer at its Genomics Core Facility.
(Feb 5, 2009)
Philips And Immunetrics Join Forces To Research Advanced Solutions For Infectious Disease In Critical Care (Medical News Today)
Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Immunetrics Inc. announced they have entered into a joint development agreement to explore future-generation approaches to the problem of infectious disease in critical care. This announcement was made at the annual Congress of the Society of Critical Care Medicine, taking place January 31 - February 4 in Nashville, Tenn.
(Feb 5, 2009)
Mosquito Genes Linked To Insecticide Resistance May Be New Target In Fight Against Malaria (Medical News Today)
Malaria remains one of the most serious diseases worldwide, claiming the lives of more than one million people per year in tropical and sub-tropical regions, the majority of whom are children under five years of age. Efforts to eliminate this mosquito-borne illness rely heavily on prevention measures, but there are growing concerns about resistance to insecticides.
(Feb 5, 2009)
New FDA Effort to Take Aim at Genomics (GenomeWeb News)
NEW YORK (GenomeWeb News) — The US Food and Drug Administration is creating a new position at the Office of FDA's Chief Scientist that will focus on the agency's genomics-related programs, FDA said this week.
(Feb 5, 2009)
TRADE NEWS: Agilent Technologies Introduces Target Enrichment Platform that Removes Major Bottleneck from ... (Centre Daily Times)
Agilent Technologies, Inc. (NYSE:A) chose the Advances in Genome Biology and Technology (AGBT) meeting to introduce the Agilent SureSelect Target Enrichment System, a unique tool for greatly streamlining DNA-sequencing research by enabling scientists to sequence only genomic areas of interest with next-generation sequencing instrumentation.
(Feb 5, 2009)
Cytomedix Further Strengthens Its Board of Directors (GlobeNewswire via Yahoo! Finance)
ROCKVILLE, Md., Feb. 5, 2009 -- Cytomedix, Inc. announced today that it has appointed C. Eric Winzer to its Board of Directors; Mr. Winzer will also serve as Audit Committee Chairman and the Audit Committee financial expert.
(Feb 5, 2009)
Industry Briefs (GenomeWeb News)
Thermo Fisher Scientific this week reported a 1-percent revenue decline in its Analytical Technologies segment during the fourth quarter of 2008 while overall receipts inched up 1 percent.
(Feb 5, 2009)
New Products (GenomeWeb News)
Bioinquire this week launched ProteoIQ , version 1.2, a bioinformatics tool for proteomics data analysis.
(Feb 5, 2009)
NIH Funding for Proteomics Fell 3 Percent in FY 2008 (GenomeWeb News)
For the period covering Oct.1, 2007, to Sept. 30, 2008, NIH funding for proteomics research declined to $125.6 million from $129.1 million in fiscal 2007.
(Feb 5, 2009)
Proxeon Raises $2.4M in Financing; Funds Will be Used to Build Sales and Marketing Capabilities (GenomeWeb News)
Building on a just-completed year in which it expects sales of its Easy-nLC platform to drive revenue growth by more than 60 percent year over year, Danish liquid-chromatography and bioinformatics firm Proxeon said this week it has secured a DKK 14 million ($2.4 million) financing round.
(Feb 5, 2009)
Luminex Corporation Reports Fourth Quarter and Year-End 2008 Results (Centre Daily Times)
Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2008. Recent financial and operating highlights include the following:
(Feb 5, 2009)
Genetic Study Shows Direct Link Between Vitamin D and Ms Susceptibility 'Gene' (ITNews)
Scientists have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS).
(Feb 5, 2009)
CLC bio updates Main Workbench, Genomics Workbench (MacNN)
CLC bio has released several updates to its genetics software, including a major overhaul to CLC Main Workbench and a minor update to CLC Genomics Workbench. Main Workbench 5.0 now supports both microarray- and sequencing-based expression data, along with new visualization options for expression analysis, including an interactive heat map and scatter plot views. Users can work with expression ...
(Feb 5, 2009)
DNA microarray may help reveal reason behind coral reefs' deaths (New Kerala)
Washington, Feb 5 : Scientists have developed a DNA microarray that may shed light on coral disease, which may help them learn how to preserve coral, one of the ocean's most important denizens.
(Feb 6, 2009)
Philips and Immunetrics join forces to research advanced solutions for infectious disease in critical care (Thaipr.net)
Royal Philips Electronics and Immunetrics Inc. announced they have entered into a joint development agreement to explore future-generation approaches to the problem of infectious disease in critical c
(Feb 6, 2009)
|
